Evidence map›Paper›PMID 26109505›Full record

ArticleJournal of the American Heart Association2015

High Cholesterol Awareness, Treatment, and Control Among Hispanic/Latinos: Results From the Hispanic Community Health Study/Study of Latinos.

Carlos J Rodriguez, Jianwen Cai, Katrina Swett, Hector M González, Gregory A Talavera, Lisa M Wruck, Sylvia Wassertheil-Smoller, Donald Lloyd-Jones, Robert Kaplan, Martha L Daviglus

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Circulating Lipids and COVID-19: Insights From Mendelian Randomization.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Interventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management.Current treatment options in cardiovascular medicine · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carlos J RodriguezDepartment of Medicine and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC (C.J.R., K.S.).
Jianwen CaiDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC (J.C.).
Katrina SwettDepartment of Medicine and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC (C.J.R., K.S.).
Hector M GonzálezDepartment of Neurology, Michigan State University, East Lansing, Michigan (H.M.G., L.M.W.).
Gregory A TalaveraDepartment of Medicine, San Diego State, San Diego, CA (G.A.T.).
Lisa M WruckDepartment of Neurology, Michigan State University, East Lansing, Michigan (H.M.G., L.M.W.).
Sylvia Wassertheil-SmollerDepartment of Epidemiology and Community Health, Albert Einstein School of Medicine, Bronx, NY (S.W.S., R.K.).
Donald Lloyd-JonesDepartment of Medicine, Northwestern University, Chicago, IL (D.L.J.).
Robert KaplanDepartment of Epidemiology and Community Health, Albert Einstein School of Medicine, Bronx, NY (S.W.S., R.K.).
Martha L DaviglusDepartment of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, IL (M.L.D.).

Funding

Epidemiologic Determinants of Change in Cardiac Structure and Function (ECHO-SOL 2)R01HL104199 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RODRIGUEZ, CARLOS JOSE · 2011 to 2018
$5.3M
NHLBI NIH HHS R01 HL104199
6 · The paper itself

Abstract

backgroundWe assessed high cholesterol (HC) awareness, treatment, and control rates among US Hispanic/Latino adults and describe factors associated with HC awareness and management. METHODS AND

resultsBaseline data (collected 2008-2011) from a multisite probability sample of Hispanic/Latino adults in the Hispanic Community Health Study/Study of Latinos (18 to 74 years old; N=16 207) were analyzed. HC was defined as low-density lipoprotein-cholesterol ≥130 mg/dL and/or total cholesterol ≥240 mg/dL or use of cholesterol-lowering medication. Among Hispanic/Latino adults with HC, almost half (49.3%) were not aware of their condition and only 29.5% were receiving treatment. Men had a higher HC prevalence than women (44.0% versus 40.5%) but a lower rate of treatment (28.1% versus 30.6%). Younger adults were significantly less likely to be HC aware compared to those who were older. Those with hypertension, diabetes, and high socioeconomic position were more likely to be HC aware. US-born Hispanic/Latino were more likely to be HC unaware than foreign-born Hispanics/Latinos, but longer US residency was significantly associated with being HC aware, treated, and controlled. Cholesterol control was achieved among 64.3% of those who were HC treated. However, younger adults, women, those with lower income, those uninsured, and more recent immigrants were less likely to be HC controlled. Individuals of Puerto Rican or Dominican background were most likely to be HC aware and treated, whereas those of Mexican or Central American background were least likely to be HC treated. Individuals of Cuban and South American background had the lowest rates of HC control, whereas Puerto Ricans had the highest.

conclusionsUnderstanding gaps in HC awareness, treatment, and control among US Hispanic/Latino adults can help inform physicians and policymakers to improve disease management and patient education programs.

Indexed as

AwarenessAdolescentAdultAgedAge FactorsAnticholesteremic AgentsBiomarkersCholesterolComorbidityCubaFemaleHealthcare DisparitiesHealth Knowledge, Attitudes, PracticeHealth Status DisparitiesHispanic or LatinoHumansAnticholesteremic AgentsBiomarkersCholesterolcholesterolepidemiologyhealth disparitieshigh‐risk populations

Identifiers

PMID26109505
PMCPMC4608071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.